JRP
RVMD icon

Jasper Ridge Partners’s Revolution Medicines RVMD Stock Holding History

Jasper Ridge Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
5,809
-8,559
-60% -$1.25M 0.02% 95
2026
Q1 		$1.4M Hold
14,368
– – 0.03% 80
2025
Q4 		$1.14M Buy
+14,368
New +$942K 0.03% 85
2021
Q1 		– Sell
-11,212
Closed -$444K – 117
2020
Q4 		$444K Buy
+11,212
New +$443K 0.02% 96

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jasper Ridge Partners's RVMD Position: Q2 2026 in Review

Jasper Ridge Partners reduced its Revolution Medicines (RVMD) stake by 60% in Q2 2026, selling an estimated $1.25M and leaving 5,809 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #95.

Jasper Ridge Partners first reported a position in RVMD in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.4M in Q1 2026. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Jasper Ridge Partners held 5,809 shares of Revolution Medicines worth $1.09M as of Q2 2026.
  • Jasper Ridge Partners sold 8,559 Revolution Medicines shares in Q2 2026, an estimated $1.25M.
  • Revolution Medicines made up 0.02% of Jasper Ridge Partners's portfolio in Q2 2026, its #95 holding.
  • Jasper Ridge Partners first reported a position in Revolution Medicines in Q4 2020 and has held it in 4 quarters since.
  • Jasper Ridge Partners's Revolution Medicines position peaked at $1.4M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.